AbbVie Wins U.S. Approval to Sell New Hepatitis C Competitor
Alert: HALISTER Source: BN (Bloomberg News)
Tickers ABBV US (AbbVie Inc) GILD US (Gilead Sciences Inc) ENTA US (Enanta Pharmaceuticals Inc) MVIRB SS (Medivir AB)
People Michael Severino (AbbVie Inc)
Topics Viral Hepatitis
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283